Ajanta Pharma Limited (NSE:AJANTPHARM)
India · Delayed Price · Currency is INR 3,586.00
-34.80 (-0.96%)
Oct 1, 2026, 3:29 PM IST
Ajanta Pharma Market Cap
Ajanta Pharma has a market cap or net worth of 447.39 billion as of October 1, 2026. Its market cap has increased by 48.87% in one year.
Market Cap
447.39B
Enterprise Value
443.42B
Revenue
57.76B
Ranking
n/a
PE Ratio
39.44
Stock Price
3,586.00
ChartMarket Cap Chart
Since April 1, 2002, Ajanta Pharma's market cap has increased from 565.80M to 447.39B, an increase of 78,973.51%. That is a compound annual growth rate of 31.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 447.39B | 29.38% |
| Dec 31, 2025 | 345.80B | -5.57% |
| Dec 31, 2024 | 366.20B | 39.58% |
| Dec 29, 2023 | 262.36B | 68.96% |
| Dec 30, 2022 | 155.28B | -19.73% |
| Dec 31, 2021 | 193.46B | 36.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cipla | 1.09T |
| Laurus Labs | 1.07T |
| Mankind Pharma | 1.05T |
| Aurobindo Pharma | 964.79B |
| Glenmark Pharmaceuticals | 657.81B |
| Alkem Laboratories | 624.13B |
| Ipca Laboratories | 493.00B |
| Gland Pharma | 474.18B |